John Hancock Funds II Science & (0P00007UXI)

Overview

The fund is strategically focused on investing in companies poised to benefit from the rapid evolution and application of science and technology. By allocating at least 80% of its net assets, along with any potential borrowings explicitly for investment purposes, into the common stocks of these pioneering entities, the fund seeks to leverage the expansive growth and innovation within this sector. This investment horizon includes, but is not restricted to, equities directly involved in science and technology advancements. Additionally, for the purpose of adhering to this investment criterion, the fund considers equity-linked notes and derivatives related to common stocks, such as options on equity-linked notes, as part of the common stock category. This approach allows for a diversified and flexible investment strategy, aiming to maximize returns by capitalizing on the science and technology sector's dynamic nature.

Products and Services

The fund offers a range of investment products designed to cater to the evolving needs of investors interested in capitalizing on the science and technology sector's growth potential. Each product or service is tailored to leverage the advancements and developments within this vibrant industry.

• Common Stocks Investment

  At its core, the fund invests substantially in the common stocks of companies expected to benefit from the science and technology sector's development. This includes a wide array of industries within the tech space, from information technology to biotechnology, ensuring investors are well-positioned to capitalize on sector-wide growth.

• Equity-Linked Notes and Derivatives

  In addition to common stocks, the fund diversifies its portfolio by investing in equity-linked notes and derivatives related to common stocks. This includes options on equity-linked notes, offering investors a nuanced way to engage with the science and technology market. These financial instruments are designed to provide potential for enhanced returns, adding depth to the investment strategy.

• Hybrid Instruments

  Recognizing the complex nature of financial markets, the fund allocates up to 10% of its total assets in hybrid instruments. This strategic move is aimed at optimizing the investment portfolio's risk-reward profile, providing a balanced approach to investing in the high-growth potential of the science and technology sector.